The TCRβ/pTα pre-TCR complex signals the expansion and differentiation of developing thymocytes. Functional properties of the pre-TCR rely on its unique pTα chain, which suggests the participation of specific intracellular adaptors. However, pTα-interacting molecules remain unknown. Here, we identified a polyproline-arginine sequence in the human pTα cytoplasmic tail that interacted in vitro with SH3 domains of the CIN85/CMS family of adaptors, and mediated the recruitment of multiprotein complexes involving all (CMS, CIN85 and CD2BP3) members. Supporting the physiological relevance of this interaction, we found that one of such adaptors, CMS, interacted in vivo with human pTα, and its expression was selectively up-regulated during human thymopoiesis in pre-TCR-activated thymocytes. Upon activation, pre-TCR clustering was induced, and CMS and polymerized actin were simultaneously recruited to the pre-TCR activation site. CMS also associated via its C-terminal region to the actin cytoskeleton in the endocytic compartment, where it co-localized with internalized pTα in traffic to lysosomal degradation. Notably, deletion of the pTα CIN85/CMS-binding motif impaired pre-TCR-mediated Ca 2+ mobilization and NFAT transcriptional activity, and precluded activation induced by over-expression of a CMS-SH3 N-terminal mutant. These results provide the first molecular evidence for a pTα intracellular adaptor involved in pre-TCR function.
Introduction
Intrathymic differentiation of αβ T lymphocytes is a complex process regulated at two consecutive checkpoints through the pre-TCR and the αβ TCR 1, 2 . Surface expression of the TCR β-pTα pre-TCR heterodimer signals the expansion and further differentiation of developing pre-T cells, a process termed β−selection [3] [4] [5] . Thereafter, replacement of the pre-TCR by the mature TCRαβ allows for positive and negative selection of developing thymocytes 1,2 .
The similar biochemical composition of the pre-TCR and the TCRαβ initially supported the view that pTα is simply a "surrogate" TCRα chain. However, pTα and
TCRα are not interchangeable partners of TCRβ during T cell development 6, 7 . Rather, the pTα molecule endows the pre-TCR with unique functional properties, such as constitutive clustering and ligand-independent activation 5, [8] [9] [10] [11] , which likely occur through oligomerization mediated by the pTα extracellular (EC) domain 12 . Other pTα structural features that could account for the unique functional properties of the pre-TCR rely on the presence of a long cytoplasmic tail that could mediate pre-TCR signaling. However, despite highly conserved at the EC and transmembrane (TM) domains, mouse and human pTα differ significantly at the cytoplasmic (CT) domain (30 and 114 amino acids, respectively). This difference, together with experimental data in mice, initially diminished the functional relevance of the pTα CT domain 13, 14 . In contrast, the human pTα CT domain was shown to serve an endoplasmic reticulum retention function that regulated pre-TCR assembly and expression 15 . Moreover, constitutive pre-TCR internalization and degradation 16, 17 was also dependent on the pTα CT domain in humans 16 . Despite these initial discrepancies, more recent data have pointed to an essential and previously unappreciated functional role for the CT tail of pTα also in mice,
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From since the C-terminal (C-term) portion of murine pTα was proved crucial for intrathymic development 18 . What exactly the pTα CT domain does to promote pre-TCR signaling remains an open question, but proper pre-TCR function seems to require the contribution of two proline-rich sequences present in its C-term portion 18 . It is thus likely that polyproline sequences within the pTα tail directly interact with molecules that could propagate signals emanating from the pre-TCR. Therefore, the characterization of those intracellular adaptors would be essential to understand the basis of the unique signaling properties of the pre-TCR. However, proteins that associate with the pTα cytoplasmic domain have not been identified as yet.
The proline-rich tandem repeat (PPTHR and PPSRK) present within the murine pTα CT domain is conserved as a single sequence (PPGRK) in humans 4 . Although different from the consensus PXXP or PPLP SH3-binding motifs, this sequence displays some homology with two tandem PPGHR sequences within the CT tail of the costimulatory molecule CD2 4, 18 . In mature T cells, this region is responsible for the direct interaction of CD2 with the intracellular adaptor CD2BP2, which is involved in signal transduction 19 . Additional molecules interact with the CD2 CT tail through distinct proline-rich domains, including the CD2BP1 adaptor, implicated in actin polymerization and T-cell adhesion, motility and activation [20] [21] [22] , and CMS and CIN85, two members of the CMS/CIN85 adaptor family shown to regulated cytoskeletal rearrangements and Tcell polarization 23, 24 .
We show in this study that, besides the conserved CD2-like proline-rich sequence, the human pTα CT domain carries a polyproline-arginine sequence that fits the atypical recognition consensus recently reported for SH3 domains of the CIN85/CMS family of adaptors 25, 26 . This sequence mediates binding of CIN85/CMS adaptors to multiple signaling molecules, including the CD2 co-receptor in T cells 23 , and regulates multiple 27 , suggesting a role in pre-TCR function as well. We provide evidence that the polyproline motif identified here in the pTα CT tail is in fact an indispensable binding site for CIN85/CMS adaptors involved in pre-TCR signaling. Therefore, our data identify CIN85/CMS proteins as the first known intracellular adaptors of human pTα required for pre-TCR function.
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Materials and methods

Cell lines and transfections
The TCRα-deficient Jurkat mutant JR3.11 28 , SupT1 pre-T cells
29
, and COS7 cells were grown in RPMI 1640 (BioWhittaker) plus 10% FCS (Gibco). Electroporations were performed using a Gene Pulser II (BioRad), as described 15 .
cDNA constructs cDNAs encoding human CIN85 or CMS were amplified by PCR from thymocyte cDNA. PCR products were cloned into either the pcDNA3-Flag or the pcDNA3-HA vector. Flag-tagged CMS and CIN85/CD2BP3 truncated forms were generated by PCR using CMS-Flag and CIN85-Flag, respectively. GST (Glutathione S-transferase) fusion proteins for the full-length pTα CT domain (GST-pTα), or for the truncated proline-rich ∆Pro1 and ∆Pro2 pTα mutants (GST-pTα∆Pro1, GST-pTα∆Pro2) were PCR-amplified using a pcDNA3-pTα vector 15 and cloned into pGEX-4T1 (Amersham Biosciences). The GST-pTα∆Pro3 construct generated from the GST-pTα construct was subcloned into pGEX-4T3 (Amersham Biosciences). Green fluorescence-(GFP-) tagged CMS constructs (CMS-GFP, SH3ABC-GFP and C-term-GFP) generated by PCR using CMS-Flag were subcloned into pEGFP-N1 (B.D Biosciences). Cloned constructs were DNA sequenced. Specific primer combinations used are shown in supplementary Table I .
GST fusion proteins and GST binding assays
GST fusion proteins were affinity-purified using glutathione-Sepharose beads (Amersham Biosciences). COS7 cells were transiently transfected with either Flag-or HA-tagged CIN85 or CMS constructs, lysed in PBS containing 1% Triton X100 (Sigma-Aldrich), protease inhibition
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From cocktail (Roche), 1 mM PMSF and 50mM NaF, and incubated with GST fusion proteins coupled to gluthatione-Sepharose beads. Bound proteins were resolved by SDS-PAGE under reducing conditions. Immunoblotting was performed using anti-Flag (M2, Sigma-Aldrich) or anti-HA (12CA5, Roche) monoclonal antibodies (mAbs) plus horseradish peroxidase-antimouse IgG (Jackson Immunoresearch).
Immunoprecipitations and immunoblotting
SupT1 cells transfected with CMS-Flag, were lysed in 0.3% Brij96V (Fluka) buffer. Immunoprecipitation was performed as described 16 with a polyclonal rabbit antibody against the human pTα cytoplasmic domain 15 , and immunoblotting was performed with anti-Flag. JRpTαWT and JRpTα∆Pro1 transduced cells were subjected to immunoprecipitation and immunoblotting using anti-Flag. Western immunoblotting of endogenous CMS and transfected Flag-tagged CMS and CMS-SH3ABC forms was performed with anti-CMS/CD2AP (H-290, Santa Cruz Biotechnology, Inc) and anti-Flag, respectively.
Retroviral infections and flow cytometry
JR3.11 cells were transduced as described 30 using the MigR1.1-GFP retroviral bicistronic vector 31 encoding Flag-tagged full-length pTαWT or pTα∆Pro1. Primer combinations used for subcloning are described in supplementary Table I . Sorted GFP + transduced cells were stained with an anti-CD3ε (UCHT1) mAb plus APC-anti-mouse Igs (BD Biosciences) and analyzed in a FACSCalibur (BD Biosciences). Background staining was determined with an irrelevant isotype-matched mAb plus APC-anti-mouse Igs.
Thymocyte subset isolation and Northern blotting
Postnatal thymocytes were isolated from thymus samples of patients aged 1 mo to 3 yr, after informed consent and approval by the CSIC Review Board was provided. The following cell 
NFAT transcriptional activation assay
JR3.11 transduced cells were transfected with a reporter plasmid encoding the luciferase gene driven by a minimal promoter containing three tandem copies of the composite NFAT/AP1-response element from the human IL-2 gene, together with a pRL-CMV Renilla reporter construct (Promega), as described 34 . After 24 h, cells were cultured for 6 h with or without plate-bound anti-CD3ε or anti-pTα mAbs and lysed using the Dual luciferase assay Kit (Promega). Firefly luciferase and Renilla luciferase activities were determined in duplicates.
The luciferase activity was normalized by the Renilla luciferase activity and expressed as foldinduction relative to the basal activity seen in non-stimulated cells.
Results
CIN85 and CMS interact with the cytoplasmic domain of human pTα through different
SH3 domains
Besides the reported CD2-like proline-rich sequence (Pro2 in Fig. 1A ) that is reiterated in mouse, the human pTα CT domain was found to carry two additional proline-based sequences: a C-term non-canonical proline-rich sequence (LPPPL) (Pro3), and a polyproline-arginine sequence (SPRPQPR) (Pro1) placed directly upstream of Pro2 (Fig. 1A) , which fits the PX(P/A)XXR or PXXXPR recognition consensus of CIN85/CMS SH3 domains identified in multiple signaling molecules 25, 26 . CIN85 and CMS adaptors share a similar structure with three SH3 domains in the amino end, a central proline-rich region and a C-term coiled-coil domain 27 (Fig. 1B) . A third member of the family, CD2BP3, is a CIN85 isoform which lacks the first SH3 domain due to an alternative splicing 24, 27 .
To investigate whether CIN85/CMS adaptors physically interact with human pTα, a GST-pTα fusion protein containing the pTα CT domain (GST-pTα) was used in pull-down assays of COS7 cells transfected with Flag-tagged full-length CIN85, CMS or CD2BP3 proteins. Immunoblotting with anti-Flag revealed that both CIN85 and CMS specifically associate with the CT tail of pTα ( To identify the specific CIN85/CMS domains involved pTα binding, GST-pTα pulldowns were performed using Flag-tagged truncated forms of either CIN85 or CMS ( Fig. 2A and 2B, respectively). CIN85-SH3ABC and -SH3AB truncated proteins were precipitated with GST-pTα at higher amounts than full-length CIN85 ( 
Identification of the specific CIN85/CMS SH3 binding motif in the human pTα cytoplasmic tail
To confirm the identity of the polyproline sequence/s in the human pTα tail responsible for the interaction with CIN85/CMS SH3 domains, pull-downs were next performed using GST-fused pTα tail mutant forms (pTα∆Pro1-3) that lacked each of the three polyproline sequences 12 shown in Figure 1A . We found that neither the distal C-term (Pro3) nor the CD2-like (Pro2)
proline-rich pTα motifs were required for CIN85/CMS binding ( Fig. 2C, D) . In contrast, deletion of the polyproline-arginine (Pro1) motif completely impaired the association of pTα to CIN85 and CMS ( Fig.2 C, D) , indicating that Pro1 is a bona fide motif for CIN85 and CMS SH3 binding. As a whole, these data provide evidence that interaction of CIN85/CMS SH3 domains with the human pTα cytoplasmic tail specifically involves the Pro1 polyprolinearginine motif, and identify human pTα as a novel CIN85/CMS interacting partner.
Recruitment of multiprotein complexes involving CMS, CIN85 and CD2BP3 adaptors to the cytoplasmic domain of the human pTα chain.
According to lack of SH3A, CD2BP3 was hardly precipitated with GST-pTα, even under overexpression conditions (Fig. 3A) . Since CMS and CD2BP3 can heterodimerize through their coiled-coil domains 27 , it is possible that CMS-CD2BP3 heterodimers could be recruited to pTα. Confirming this possibility, CD2BP3 was co-precipitated with CMS in a dose-dependent manner from COS7 cells transfected with CMS and increasing amounts of CD2BP3 (Fig. 3B) .
Similar experiments performed using HA-tagged CIN85 and Flag-tagged CD2BP3 showed that CD2BP3 was also co-precipitated with CIN85 bound to pTα (Fig. 3C) . Therefore, both CMS and CIN85 can mediate the recruitment of CD2BP3 to the pTα CT domain. Finally,
GST-pTα pull-downs performed in COS7 cells transfected with CMS, CD2BP3, and increasing amounts of CIN85 revealed that CIN85 did not impair binding of CMS to pTα, nor CD2BP3 recruitment (Fig. 3D) . In contrast, amounts of CMS and CD2BP3 co-precipitated with pTα increased in the presence of CIN85 in a dose-dependent manner (Fig. 3D) . As a whole, we can conclude that multiprotein complexes involving CMS, CIN85 and CD2BP3
adaptors can be recruited to the CT domain of the human pTα chain, likely owing to heterooligomerization mediated by their coiled-coil domains. 
CMS co-localizes with the actin cytoskeleton to the pTα endocytic pathway
To get some insights into the function of CMS, we first assessed its subcellular distribution using SupT1 pre-T cells expressing GFP-tagged CMS. Confocal microscopy analysis showed that CMS-GFP expression was mostly confined to cytosolic vesicular structures that fully colocalized with polymerized actin (Fig. 5A ). Actin-rich vesicles were present as well in vivo in
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From 14 primary human pre-TCR+ thymocytes (Suppl. Fig.1A ), but not in mature T cells, in which CMS showed a diffuse expression throughout the cytosol (Suppl. Fig. 1B) , as reported for murine T cells 36 . These data suggest that formation of CMS/actin-rich vesicles is constitutive and pre-T cell-specific. Since CMS contains four acting-binding domains in its C-term region 27 , we next assessed whether the C-term is responsible for the association of CMS to the actin cytoskeleton in the vesicles found in pre-T cells. We found that over-expression of a GFP-tagged truncated form of CMS involving the three SH3 domains (SH3ABC) altered the vesicular pattern and prevented the co-localization of CMS to the actin cytoskeleton, this resulting in a diffuse intracellular distribution of GFP. In contrast, formation of CMS/actin-rich vesicles was conserved when a C-term CMS mutant lacking the SH3ABC domains was over-expressed ( Fig.   5A ). Therefore, the C-term domain is responsible for the vesicular distribution and the colocalization of CMS with polymerized actin found in pre-T cells. Inmunofluorescence analyses performed to assess the identity of the constitutive CMS/actin-rich vesicles formed in pre-T cells (Fig. 5B) revealed that GFP-CMS partly co-localized with the early endosomal compartment marker EEA1, and with CD63, which marks late endosomes and lysosomes 37 , but colocalization with the lysosomal marker Lamp1 was hardly found (mean co-localization percentage ± SEM 26.2 ± 1.3, 30.5 ± 2.2, and 15.9 ± 2.1, respectively). These data indicate that CMS localizes constitutively to the endocytic compartment, but is mostly excluded from the lysosomal compartment in pre-T cells.
Since pre-T cells are able to internalize and degrade the pre-TCR in an autonomous manner 16, 17 , it is possible that CMS/actin-rich vesicles participate in constitutive endocytosis of the pre-TCR. To investigate whether CMS+ vesicles do actually contain internalized pre-TCR proteins, the constitutive fate of surface pre-TCR complexes was monitored over time in nonstimulated CMS-GFP-expressing Sup-T1 cells, fixed at various times after labeling with an anti-pTα mAb 10 . Confocal microscopy analysis showed that the pTα chain was efficiently (Fig. 5C ). By this time, a major fraction of labeled pTα (up to 55%) co-localized to CMS-rich vesicles, and a minor proportion (less than 30%) colocalized with Lamp1+ lysosomes, from which CMS was excluded. Over time, increasing proportions of pTα localized to lysosomes (up to 70% within 30 min, Suppl. Fig. 2 ), but CMS and Lamp1 co-localization was difficult to observe (not shown), confirming that CMS and pTα co-localize exclusively at the endocytic compartment. Notably, neither CMS nor polymerized actin co-localized with the conventional TCRαβ complex internalized upon receptor engagement on mature T cells (Suppl. Fig.3 ), supporting a selective role for the CMS endocytic pathway in pre-T cells. As a whole, these results indicate that CMS co-localizes with polymerized actin to the pTα endocytic pathway, and marks pTα trafficking to lysosome degradation. Accordingly, disruption of the actin cytoskeleton by cytochalasin D treatment abrogated pTα transport to lysosomes in pre-T cells and resulted in the accumulation of pTα in early endosomes (Suppl. Fig. 2 ).
CMS-rich clusters co-localize with polymerized actin at the site of pre-TCR activation
In mature T cells, interaction of CMS with the CD2 co-receptor is involved in CD2 clustering and cytoskeletal reorganization following CD2 ligand attachment 23 . We thus assessed whether CMS participates in pre-TCR patterning following pre-T cell activation. As shown in Figure   6A , CD3ε engagement of CMS-GFP-transfected SupT1 cells resulted in the redistribution and clustering of the pre-TCR on the cell surface. Notably, CMS-rich clusters appeared at the area of pre-TCR engagement and co-localized with the pre-TCR. To confirm that CMS is recruited to the site of pre-TCR activation, the fate of CMS was then monitored over time in SupT1 cells fixed at various times after pre-TCR stimulation with anti-CD3ε-coated magnetic beads ( 
Binding of CMS to the proline-arginine motif in the human pTα cytoplasmic tail is involved in pre-TCR signaling
It has been shown that activation through the murine pre-TCR promotes Ca 2+ -dependent signals 8 . To investigate whether the CIN85/CMS binding motif of human pTα is involved in pre-TCR signaling, Ca 2+ mobilization was assessed after pre-TCR cross-linking in TCRα-deficient Jurkat cells (JR3.11) 28 , in which Flag-tagged versions of either a wild-type or a ∆Pro1 mutant pTα chain were co-expressed with GFP by retroviral transduction. Anti-Flag immunoprecipitations of GFP + sorted cells showed comparable levels of expression of the wild type and mutant pre-TCRs (Fig. 7A) , and equivalent surface expression was observed as well by flow cytometry (Fig. 7B) . Also, western immunoblotting with anti-CMS revealed similar expression levels of endogenous CMS (Fig. 7A) . As shown previously in pre-T cells ]i rise, which consisted of an initial rapid rise followed by a slow decrease. However, Ca 2+ mobilization was markedly defective in JR.311 cells bearing the mutant pTα∆Pro1 chain (Fig. 7C) , indicating that the proline-arginine CIN85/CMS binding motif is required for proper pre-TCR signaling. JRpTαWT and JRpTα∆Pro1 cells using a luciferase-reporter assay 34 . As shown in Fig. 7D , pre-TCR crosslinking with an anti-pTα mAb promoted a marked luciferase increase in
JRpTαWT cells, while NFAT activity was significantly lower in JRpTα∆Pro1 mutants.
Notably, over-expression of a truncated CMS form encompassing exclusively the SH3ABC domains ( Fig. 7 E) significantly enhanced pre-TCR-mediated NFAT transcriptional activity in JRpTαWT cells, while this effect was prevented in pTα∆Pro1 mutants (Fig. 7F) , supporting that SH3ABC-promoted NFAT activation depends on pTα binding. In contrast, overexpression of either the entire CMS molecule (Fig. 7E) , or a CMS C-term form lacking the SH3 domains (not shown), markedly reduced NFAT transcriptional activity in both JRpTαWT and pTα∆Pro1 cells (Fig. 7F ), this revealing a dominant negative role for CMS on NFAT activation independent of pTα binding. However, over-expressed CMS did not significantly affect Ca2+ mobilization in JRpTαWT cells (Suppl. Fig. 4 ), thus precluding a dominant negative role of CMS on Ca2+ mobilization. As a whole, our results showing that binding of CMS SH3 domains to the proline-arginine motif of pTα is in fact relevant for pre-TCR signaling provide the first molecular evidence for a cytosolic adaptor of the pTα chain involved in pre-TCR function.
Discussion
Current views support that the exclusive capability of the pre-TCR complex in promoting Tcell development maps to the CT domain of its pTα chain 7, 18 . It is thus expected that pTα interacts with intracellular adaptors that propagate specific pre-TCR signals and, therefore, identification of such regulators is key for understanding the unique signaling properties of the pre-TCR. However, identification of pTα interacting partners has remained elusive. Here, we provide biochemical evidence that members of the CIN85/CMS family of adaptors are cytosolic interactors of human pTα. Binding of CIN85/CMS to the pTα CT domain did not involve the reported CD2-like proline-rich sequence conserved in mouse pTα 4, 18 . Rather, we Despite high sequence identity of CIN85 and CMS SH3 domains, CMS bound to pTα more efficiently than CIN85, which concurs with the observation that distinct SH3 domains of CIN85 and CMS were involved in pTα interaction. Since CIN85, but not CMS, SH3 domains interact with proline-rich sequences within the same molecule 24 , it was expected that fulllength CIN85 interacted with pTα less efficiently than its SH3ABC and SH3AB forms. and CD2BP3 can be synergistically associated to pTα. Thus, it can be proposed that CMS acts as a scaffolding molecule, which enables pre-TCR clustering required for propagation of autonomous cell signaling.
Besides the role of SH3 domains in mediating CMS-pTα interactions, the C-term region of CMS was shown to mediate CMS association with the actin cytoskeleton and CMS localization to the pTα endocytic pathway. It is thus possible that CMS participates in the regulation of endosomal vesicle formation in pre-T cells, as proposed in other cells 42 . Our results also suggest a functional role for CMS in pTα trafficking to lysosomal degradation, which could finally result in attenuation of pre-TCR signaling. This possibility is strongly supported by the finding that CMS is up-regulated during thymocyte development in post-β selected thymocytes. However, so far we have failed to provide evidence that the CMS-pTα interaction directly participates in pre-TCR internalization and/or degradation, although such a role could depend on an indirect association of CMS mediated through c-Cbl, as has been reported for other signaling receptors including the EGFR and the TCR 40, 43 . It has recently been shown that the impaired ability of CD2AP/CMS-deficient T cells to degrade the activated TCR indirectly resulted from an impaired receptor activation, suggesting that CMS-mediated receptor clustering may finally balance TCR signaling and degradation 40 . A similar CMSdependent mechanism could finally regulate pre-TCR signaling and degradation, but an
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From additional level of complexity can be expected considering that the proline-rich region of CIN85/CMS acts as an interaction module for SH3-containing signaling proteins, such as p85α PI3K, Grb2 or Src kinases 27 , involved in T cell (and likely, pre-T cell) signaling. As a result, distinct parts of the CMS molecule could elicit divergent functional activities, whose interplay could finally determine the pre-TCR signaling output. According to this view, the SH3ABC CMS domains behave as constitutively active CMS forms upon binding to the proline-arginine motif of pTα, while full-length CMS markedly impaired SH3ABC-induced NFAT activation.
Since the inhibitory effect of CMS was independent of pTα interaction, and involved the Cterm portion of the molecule (not shown), it could result from the specific binding and sequestration of molecular effectors, downstream of Ca2+ mobilization, involved in NFAT transactivation and pre-TCR signaling. As discussed above, the dominant negative effect of CMS could also reflect an active role of the molecule in promoting and unbalance toward pTα degradation. Therefore, it is possible that distinct parts of the CMS molecule may differentially affect particular functions whose interplay and coordination finally determine pre-TCR signaling output.
While unraveling the molecular basis of CMS-mediated pre-TCR signaling will require further studies, our results provide the first molecular evidence that the CT domain of pTα provides the pre-TCR with the unique capacity to recruit CIN85/CMS adaptors crucial for propagation of downstream signals. Therefore, as previously proposed, the cytoplasmic tail of pTα could confer on the pre-TCR the capacity to "co-stimulate" 4 , while self-oligomerization of pTα would be the mechanism responsible for initiation of ligand-independent pre-TCR signaling 12 . Both signals, however, are delivered separately via engagement of the TCR and the co-stimulatory molecule CD2 in mature T cells.
For 
